9. “Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma” has already been completed with the sponsorship of AIDS Malignancy Consortium and collaboration of the National Cancer Institute and the EMMES Corporation.
